Market Overview

Wedbush's Nierengarten on ASH Late-Breaker Related to BCMA CAR-T Therapy Showing Anti-Myeloma Activity: Says Sees Read Through to bluebird bio

Share:

This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Latest Ratings for BLUE

DateFirmActionFromTo
May 2018BMO CapitalMaintainsOutperformOutperform
Mar 2018Morgan StanleyMaintainsEqual-WeightEqual-Weight
Mar 2018Janney CapitalInitiates Coverage OnNeutral

View More Analyst Ratings for BLUE
View the Latest Analyst Ratings

Posted-In: Analyst Color News Analyst Ratings

 

Related Articles (BLUE)